Related Experiment Video

Updated: Feb 19, 2026

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
10:33

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure

Published on: May 27, 2022

7.0K

An invisible threat: mutation-mediated resistance to triazole drugs in Aspergillus

Cau D Pham1, Shawn R Lockhart1

  • 1Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA.

Current Fungal Infection Reports
|November 10, 2017
PubMed

Insights

Aspergillosis is a growing threat in vulnerable groups, with increasing cases resistant to standard triazole treatments. Understanding resistance mechanisms is crucial for managing this infection in at-risk populations.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Aspergillosis is a significant cause of illness and death in immunocompromised individuals.
  • There is a concerning rise in both vulnerable populations and cases of aspergillosis resistant to triazole antifungal drugs.
  • The limited antifungal drug options amplify the impact of triazole resistance.

Purpose of the Study:

  • To review populations at risk for developing aspergillosis.
  • To highlight the mechanisms of antifungal resistance in *Aspergillus* species.
  • To discuss the implications of resistance for patient outcomes.

Main Methods:

  • Literature review of recent studies on aspergillosis epidemiology and antifungal resistance.
  • Analysis of clinical data regarding treatment outcomes in susceptible populations.
  • Examination of molecular and clinical mechanisms of triazole resistance.

Main Results:

  • Identification of specific patient groups with increased aspergillosis risk.
  • Documentation of emerging triazole-resistant *Aspergillus* strains globally.
  • Correlation between resistance mechanisms and increased patient morbidity and mortality.

Conclusions:

  • Aspergillosis management is challenged by increasing patient vulnerability and antifungal resistance.
  • Further research into resistance mechanisms and alternative therapies is essential.
  • Enhanced surveillance and targeted treatment strategies are needed for at-risk populations.

More Related Videos

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

14.3K
Inhibition of Aspergillus flavus Growth and Aflatoxin Production in Transgenic Maize Expressing the α-amylase Inhibitor from Lablab purpureus L.09:21

Inhibition of Aspergillus flavus Growth and Aflatoxin Production in Transgenic Maize Expressing the α-amylase Inhibitor from Lablab purpureus L.

Published on: February 15, 2019

11.3K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
1.6K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.6K
Mismatch Repair01:36

Mismatch Repair

Overview
43.9K
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
16
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
24